Why the study?
Simple and cost-effective tools for hip surgery risk assessment are needed, and heart rate variability analysis may provide insights into frailty and differentiate health profiles across surgical groups.
Do cardiovascular and anthropometric parameters differ between patients with hip fracture surgery, total hip arthroplasty, and controls?
Do cardiovascular and anthropometric parameters differ between patients with hip fracture surgery, total hip arthroplasty, and controls?
Heart rate variability parameters differentiate hip fracture surgery patients from controls, but do not significantly differ between patients undergoing hip fracture surgery versus total hip arthroplasty.
HRV may flag frailty differences in hip fracture patients; leaves open differentiation between surgery types or clinical adoption.
BACKGROUND: With the rising number of hip surgeries, simple and cost-effective tools for surgery risk assessment are warranted. The analysis of heart rate variability (HRV) may not only provide critical insights into the general frailty of patients with hip surgery, but also allow for better differentiation of health profiles in different hip surgery groups. Using HRV analysis, the present study compared cardiovascular as well as anthropometric parameters between patients with hip surgery, the hip fracture surgery group (HFS) and the total hip arthroplasty group (THA), and a control group. METHODS: 71 participants (56.3% women), aged 60-85 years, took part, divided into three groups-patients after hip surgery (21 HFS and 30 THA patients) and a control group (20 participants). Electrocardiogram was recorded at baseline and after the application of a physical stressor (grip strength). A 3 (group) × 2 (time) repeated measures ANOVA, and a chi square test were carried out to test for group differences. RESULTS: Higher weight (p = .002), body mass index (p = .001), and systolic blood pressure (p = .034) were found in THA patients compared to HFS patients. Lower calf circumference (p = .009) and diastolic blood pressure (p = .048) were observed for the HFS group compared to the control group. For cardiovascular parameters, significant differences emerged between the HFS group and the control group in HR (p = .005), SDNN (p = .034) and SD2 (p = .012). No significant differences in cardiovascular parameters were observed between the two hip surgery groups: neither at baseline nor during stressor recovery. CONCLUSIONS: While HRV seems to differentiate well between HFS patients and controls, more research with larger samples is needed to scrutinize similaritites and differences in cardiovascular profiles between HFS and THA patients.
No takes yet. Share an insight, caveat, or question.
Csanády-Leitner et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: